Suppr超能文献

中国疫苗安全相关事件中的利润考量。

Profit considerations in vaccine safety-related events in China.

机构信息

School of Public Health, Fudan University, Shanghai, China.

Department of General Affairs and Emergency Response, Changing District Centers for Disease Control and Prevention, Shanghai, China.

出版信息

Expert Rev Vaccines. 2019 Nov;18(11):1187-1199. doi: 10.1080/14760584.2019.1688150. Epub 2019 Nov 13.

Abstract

: China has made remarkable achievements in the field of immunization. However, several widespread vaccine safety-related events have recently received worldwide attention and reflect flaws in vaccine management. This study aimed to summarize vaccine safety-related events between 1985 and 2018 in China and analyze the profit motives of these events.. Literature and media reviews were conducted to discover vaccine safety-related events. We developed a conceptual model with profit-related variables, and using information available from each event, we identified which profit-related variable was implicated, and how it related to the pursuit of higher profits.: A total of 39 vaccine safety-related events were found in vaccine production, procurement, transportation, and daily management, along with adverse events following immunization (AEFIs). Overall, 90% (35/39) of the events could be classified as profit-driven. The motives of most events could be tied to one or more reasons, including decreasing costs among vaccine producers (67%, 26/39), reducing actual procurement price (67%, 26/39), and reducing costs of transportation and/or cold chain (24/39, 62%).: In order to deal with vaccine-related challenges, a more restrictive supervision system on vaccine production and more emergency preparedness, including health and risk communication strategies, for vaccine safety should be implemented.

摘要

中国在免疫领域取得了显著成就。然而,最近一些广泛关注的疫苗安全相关事件引起了全球关注,反映出疫苗管理存在缺陷。本研究旨在总结 1985 年至 2018 年期间中国发生的疫苗安全相关事件,并分析这些事件的盈利动机。通过文献和媒体回顾发现了疫苗安全相关事件。我们制定了一个包含盈利相关变量的概念模型,并利用每个事件的可用信息,确定了哪些盈利相关变量受到影响,以及它们与追求更高利润的关系。在疫苗生产、采购、运输和日常管理以及预防接种后不良反应(AEFIs)方面,共发现 39 起疫苗安全相关事件。总体而言,90%(35/39)的事件可归类为盈利驱动。大多数事件的动机可以归结为一个或多个原因,包括疫苗生产商降低成本(67%,26/39)、降低实际采购价格(67%,26/39)和降低运输和/或冷链成本(24%,26/39,62%)。为了应对疫苗相关挑战,应实施更严格的疫苗生产监管制度,并为疫苗安全做好更充分的应急准备,包括卫生和风险沟通策略。

相似文献

1
Profit considerations in vaccine safety-related events in China.中国疫苗安全相关事件中的利润考量。
Expert Rev Vaccines. 2019 Nov;18(11):1187-1199. doi: 10.1080/14760584.2019.1688150. Epub 2019 Nov 13.
4
Adversomics: a new paradigm for vaccine safety and design.药物不良反应组学:疫苗安全性与设计的新范式
Expert Rev Vaccines. 2015 Jul;14(7):935-47. doi: 10.1586/14760584.2015.1038249. Epub 2015 May 2.
6
Vaccine safety and social media in China.中国的疫苗安全与社交媒体
Am J Infect Control. 2016 Oct 1;44(10):1194-1195. doi: 10.1016/j.ajic.2016.04.248. Epub 2016 Jul 26.

引用本文的文献

本文引用的文献

1
Trust collapse caused by the Changsheng vaccine crisis in China.信任崩塌:中国长生疫苗危机
Vaccine. 2019 Jun 6;37(26):3419-3425. doi: 10.1016/j.vaccine.2019.05.020. Epub 2019 May 13.
9
What to do about resistant bacteria in the food-chain?食物链中的耐药菌该如何应对?
Bull World Health Organ. 2015 Apr 1;93(4):217-8. doi: 10.2471/BLT.15.030415.
10
Global harmonisation in vaccine price.疫苗价格的全球协调统一。
Lancet Infect Dis. 2015 Mar;15(3):249. doi: 10.1016/S1473-3099(15)70067-8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验